Form D Explorer

Inspect source fieldsReport a record issue

Form D — Xilis, Inc.

0001231919-25-000033 · filed Apr 25, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$19,405,205
Reported amount sold
$19,405,205
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Xilis, Inc.
CIK
1796056
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
31 ALEXANDRIA WAY
DURHAM, North Carolina 27713
Phone
(984) 377-6738

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗